Cognitive Determinants of Psychoeducation and Information in Psychoses (COGPIP)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2008 by German Research Foundation.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
German Research Foundation
ClinicalTrials.gov Identifier:
NCT00646256
First received: March 25, 2008
Last updated: NA
Last verified: March 2008
History: No changes posted
  Purpose

The aim of the study is to examine whether the efficacy of psychoeducation in patients with schizophrenia or schizoaffective disorders is dependent on their cognitive performance level and if a preceding cognitive training can enhance the therapeutic effects of psychoeducation


Condition Intervention
Schizophrenia
Delusional Disorders (ICD-10)
Behavioral: COGPACK training, psychoeducation

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Psychoeducation in Patients With Schizophrenia: Neuropsychological Performance and Cognitive Training as Determinants of Outcome

Resource links provided by NLM:


Further study details as provided by German Research Foundation:

Primary Outcome Measures:
  • illness knowledge, adherence to treatment, insight to the illness, satisfaction with treatment. 9-month follow-up: number of rehospitalizations, days in hospital [ Time Frame: Baseline, after cognitive training, after psychoeducation, 9-month after end of psychoeducation ]

Secondary Outcome Measures:
  • Psychopathological status
  • Psychosocial rehabilitation

Estimated Enrollment: 120
Study Start Date: February 2006
Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: no training
Experimental: COGPACK training Behavioral: COGPACK training, psychoeducation
Bifocal psychoeducation group program (Munich Psychoses Information Program - PIP) with preceding computerbased cognitive training program (COGPACK)

Detailed Description:

Schizophrenic inpatients are examined shortly after admission with a broad battery of clinical and neurological rating scales and neuropsychological tests. They are then randomized to either standard treatment (including antipsychotic medications, art and occupational therapy, psychotherapy) or to standard treatment plus daily computerbased cognitive training (COGPACK; ten 1-hour sessions over two weeks). After repetition of the broad assessment battery all patients (and some of their family members) take part in a bifocal psychoeducation group program (eight 1-hour sessions over four weeks). Specific pre-post measures are illness knowledge, self and expert ratings of adherence to treatment, insight to the illness, treatment satisfaction. The study also includes a 9-month follow-up, with number of rehospitalizations, days in hospital and psychopathology as the primary outcome measures.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Inpatients
  • Informed consent
  • German as first language or very good knowledge of German

Exclusion Criteria:

  • Mental retardation
  • Any serious somatic illness
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00646256

Contacts
Contact: Thomas Jahn, Prof. Dr. phil. Dipl.-Psych. +49 (0)89-4140 4278 th.jahn@lrz.tum.de

Locations
Germany
Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum rechts der Isar, Technical University of Munich Recruiting
Munich, Germany, 81675
Sponsors and Collaborators
German Research Foundation
Investigators
Principal Investigator: Thomas Jahn, Prof. Dr. phil. Dipl.-Psych. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klnikum rechts der Isar, Technbical Univesity Munich
  More Information

No publications provided by German Research Foundation

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Prof. Dr. phil. Dipl.-Psych. Thomas Jahn, Technical University of Munich
ClinicalTrials.gov Identifier: NCT00646256     History of Changes
Other Study ID Numbers: DFG Ja 680 / 4-2, 4-3
Study First Received: March 25, 2008
Last Updated: March 25, 2008
Health Authority: Germany: Ethics Commission

Keywords provided by German Research Foundation:
schizoaffective
schizotypal

Additional relevant MeSH terms:
Schizophrenia, Paranoid
Delusions
Schizophrenia
Schizophrenia and Disorders with Psychotic Features
Mental Disorders
Behavioral Symptoms

ClinicalTrials.gov processed this record on August 28, 2014